SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-258923
Filing Date
2022-10-06
Accepted
2022-10-06 16:53:34
Documents
12
Period of Report
2022-10-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d339116d8k.htm   iXBRL 8-K 37475
  Complete submission text file 0001193125-22-258923.txt   166742

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA endp-20221006.xsd EX-101.SCH 2849
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE endp-20221006_lab.xml EX-101.LAB 18691
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE endp-20221006_pre.xml EX-101.PRE 11682
6 EXTRACTED XBRL INSTANCE DOCUMENT d339116d8k_htm.xml XML 3546
Mailing Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000
Business Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000 353-1-268-2000
Endo International plc (Filer) CIK: 0001593034 (see all company filings)

IRS No.: 680683755 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36326 | Film No.: 221298613
SIC: 2834 Pharmaceutical Preparations